US Patent Issued to ALPHABETA on July 21 for "Compound and method for treatment of alzheimer's disease" (Swedish Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,706, issued on July 21, was assigned to ALPHABETA AB (Djursholm, Sweden).

"Compound and method for treatment of alzheimer's disease" was invented by Jan Johansson (Stockholm).

According to the abstract* released by the U.S. Patent & Trademark Office: "An isolated protein comprising a moiety of 90-200 amino acid residues having at least 70% identity to Bri2 BRICHOS, wherein the amino acid residue corresponding to Arg in position 221 in full-length Bri2 wt is not Arg, Lys or His. The protein is useful as a medicament for use in treatment of Alzheimer's Disease."

The patent was filed on Jan. 7, 2021, under Application No. 17/784,591.

*For further information, including images, cha...